Novo Nordisk
Company Details
Linkedin ID:
novo-nordisk
Website:
Employees number:
65,152
Number of followers:
2,662,971
NAICS:
3254
Industry Type:
Homepage:
novonordisk.com
IP Addresses:
0
Company ID:
NOV_1789310
Scan Status:
In-progress
Internal validation & live display
Multiple badges & continuous verification
Faster underwriting decisions
Novo Nordisk Vendor Cyber Rating & Cyber Score
novonordisk.comWe’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health. Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 77,000 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to block and remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.html For other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.html Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users. Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html
Novo Nordisk A.I CyberSecurity Scoring
Novo Nordisk Risk Score (AI oriented)Between 800 and 849
Novo Nordisk
Updated:
- Powered by our proprietary A.I cyber incident model
- Insurance preferes TPRM score to calculate premium
Novo Nordisk Global Score (TPRM)XXXX
Novo Nordisk
- Instant access to detailed risk factors
- Benchmark vs. industry & size peers
- Vulnerabilities
- Findings
Novo Nordisk Company CyberSecurity News & History
Past Incidents
0
Attack Types
0
No data available
Novo Nordisk Company Scoring based on AI Models
Cyber Incidents Likelihood 3 - 6 - 9 months
A.I Risk Score Likelihood 3 - 6 - 9 months
Underwriter Stats for Novo Nordisk
Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)
No incidents recorded for Novo Nordisk in 2026.
Incidents vs All-Companies Average (This Year)
No incidents recorded for Novo Nordisk in 2026.
Incident Types Novo Nordisk vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Novo Nordisk in 2026.
Incident History — Novo Nordisk (X = Date, Y = Severity)
Novo Nordisk cyber incidents detection timeline including parent company and subsidiaries
Novo Nordisk Company Subsidiaries
We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health. Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 77,000 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to block and remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.html For other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.html Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users. Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html
Loading...
Novo Nordisk Similar Companies
Catalent
Championing the missions that matter™. Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) and trusted partner to pharma, biotech, and consumer health companies worldwide. We put patients first in everything we do, helping people live better and healthier li
Astellas Pharma
Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneer
Parexel
Parexel is a leading global clinical research organization (CRO) providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry. Leveraging deep local knowledge and a global breadth of clinical, regulatory and therapeutic expertise, our 24,000+ professionals worldw
At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating wit
Zoetis
The world’s leading animal health company. We’ve been innovating ways to predict, prevent, detect, and treat animal illness for over 70 years, and we continue to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers. Our leading portfolio an
Intas Pharmaceuticals
Intas is one of the leading multinational pharmaceutical formulation development, manufacturing, and marketing organization in the world. It has been growing at 19% CAGR and crossed the $2.5 billion mark in the past financial year. The company has set up a network of subsidiaries, under the name Acc
We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by list
Ipca Laboratories Limited
A consumer-led global pharmaceutical company, creating healthy doses of life since 1949. When you operate in an industry like pharmaceuticals, your work goes way beyond creating ‘products for customers’. It is different from any other domain – there lies a higher sense of responsibiliti and a need
Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out mor
.png)
Novo Nordisk CyberSecurity News
March 27, 2026 12:06 AM
RSAC CEO Jen Easterly talks key cybersecurity themes ahead of conference
RSAC CEO Jen Easterly talks key cybersecurity themes ahead of conference. RSAC CEO Jen Easterly talks key cybersecurity themes ahead of...
March 26, 2026 08:54 PM
Accenture (NYSE:ACN) Expands AI Platforms Across Cybersecurity
Nyse Composite reflects Accenture AI expansion strengthening security and commerce.
March 26, 2026 12:55 AM
FDA warns Novo Nordisk on weight loss drug reports
The FDA warned Novo Nordisk over unreported weight loss drug side effects, citing two deaths and a suicidal ideation case.
February 25, 2026 08:00 AM
Florida State University Researcher Receives 2025 Novo Nordisk Fellowship for Quantum Materials Study
A Florida State University researcher received a 2025 Novo Nordisk Fellowship to advance the development of new materials containing quantum...
February 24, 2026 08:00 AM
CNBC Daily Open: Unstable tariff situation and new AI disruption spark market sell-off
Investors lost their sense of security in the business of cybersecurity companies after Anthropic on Friday launched an AI-powered security...
February 23, 2026 08:00 AM
Market movers: Novo Nordisk, Domino's Pizza, TomCo Energy...
Anthropic's recent launch of its Claude Code Security offering has stirred volatility across cybersecurity stocks, but analysts at Wedbush...
February 18, 2026 08:00 AM
FSU Researcher Awarded Novo Nordisk Fellowship for Quantum Materials Study
Florida State University chemist Michael Shatruk has received a 2025 Novo Nordisk Fellowship to research molecule-based quantum materials in...
December 28, 2025 08:00 AM
High Growth Indian Stocks Linked to GLP-1 Drugs, Data Centres and Cybersecurity
Over the coming years, structural shifts are set to reshape key sectors of the Indian economy, creating potential investment opportunities.
December 23, 2025 08:00 AM
These Stocks Moved the Most Today: Novo Nordisk, ServiceNow, Micron, DJT, Freeport-McMoRan, Zim, and More
Novo Nordisk surges after U.S. regulators approve the first GLP-1 pill, while shares of rival pharma giant Eli Lilly decline.
Frequently Asked Questions
Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
Novo Nordisk CyberSecurity History Information
Official Website of Novo Nordisk
The official website of Novo Nordisk is https://www.novonordisk.com.
Novo Nordisk’s AI-Generated Cybersecurity Score
According to Rankiteo, Novo Nordisk’s AI-generated cybersecurity score is 830, reflecting their Good security posture.
How many security badges does Novo Nordisk’ have ?
According to Rankiteo, Novo Nordisk currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
Has Novo Nordisk been affected by any supply chain cyber incidents ?
According to Rankiteo, Novo Nordisk has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.
Does Novo Nordisk have SOC 2 Type 1 certification ?
According to Rankiteo, Novo Nordisk is not certified under SOC 2 Type 1.
Does Novo Nordisk have SOC 2 Type 2 certification ?
According to Rankiteo, Novo Nordisk does not hold a SOC 2 Type 2 certification.
Does Novo Nordisk comply with GDPR ?
According to Rankiteo, Novo Nordisk is not listed as GDPR compliant.
Does Novo Nordisk have PCI DSS certification ?
According to Rankiteo, Novo Nordisk does not currently maintain PCI DSS compliance.
Does Novo Nordisk comply with HIPAA ?
According to Rankiteo, Novo Nordisk is not compliant with HIPAA regulations.
Does Novo Nordisk have ISO 27001 certification ?
According to Rankiteo,Novo Nordisk is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
Industry Classification of Novo Nordisk
Novo Nordisk operates primarily in the Pharmaceutical Manufacturing industry.
Number of Employees at Novo Nordisk
Novo Nordisk employs approximately 65,152 people worldwide.
Subsidiaries Owned by Novo Nordisk
Novo Nordisk presently has no subsidiaries across any sectors.
Novo Nordisk’s LinkedIn Followers
Novo Nordisk’s official LinkedIn profile has approximately 2,662,971 followers.
NAICS Classification of Novo Nordisk
Novo Nordisk is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.
Novo Nordisk’s Presence on Crunchbase
No, Novo Nordisk does not have a profile on Crunchbase.
Novo Nordisk’s Presence on LinkedIn
Yes, Novo Nordisk maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/novo-nordisk.
Cybersecurity Incidents Involving Novo Nordisk
As of April 04, 2026, Rankiteo reports that Novo Nordisk has not experienced any cybersecurity incidents.
Number of Peer and Competitor Companies
Novo Nordisk has an estimated 5,608 peer or competitor companies worldwide.
Novo Nordisk CyberSecurity History Information
How many cyber incidents has Novo Nordisk faced ?
Total Incidents: According to Rankiteo, Novo Nordisk has faced 0 incidents in the past.
What types of cybersecurity incidents have occurred at Novo Nordisk ?
Incident Types: The types of cybersecurity incidents that have occurred include .
Incident Details
What are the most common types of attacks the company has faced ?
Additional Questions
.png)
Latest Global CVEs (Not Company-Specific)
Description
nimiq/core-rs-albatross is a Rust implementation of the Nimiq Proof-of-Stake protocol based on the Albatross consensus algorithm. Prior to version 1.3.0, two peer-facing consensus request handlers assume that the history index is always available and call blockchain.history_store.history_index().unwrap() directly. That assumption is false by construction. HistoryStoreProxy::history_index() explicitly returns None for the valid HistoryStoreProxy::WithoutIndex state. when a full node is syncing or otherwise running without the history index, a remote peer can send RequestTransactionsProof or RequestTransactionReceiptsByAddress and trigger an Option::unwrap() panic on the request path. This issue has been patched in version 1.3.0.
Risk Information
cvss3
Base: 5.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:L
Description
PraisonAI is a multi-agent teams system. Prior to version 1.5.95, FileTools.download_file() in praisonaiagents validates the destination path but performs no validation on the url parameter, passing it directly to httpx.stream() with follow_redirects=True. An attacker who controls the URL can reach any host accessible from the server including cloud metadata services and internal network services. This issue has been patched in version 1.5.95.
Risk Information
cvss3
Base: 8.6
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:N/A:N
Description
PraisonAI is a multi-agent teams system. Prior to version 4.5.97, OAuthManager.validate_token() returns True for any token not found in its internal store, which is empty by default. Any HTTP request to the MCP server with an arbitrary Bearer token is treated as authenticated, granting full access to all registered tools and agent capabilities. This issue has been patched in version 4.5.97.
Risk Information
cvss3
Base: 9.1
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N
Description
PraisonAI is a multi-agent teams system. Prior to version 4.5.97, the PraisonAI Gateway server accepts WebSocket connections at /ws and serves agent topology at /info with no authentication. Any network client can connect, enumerate registered agents, and send arbitrary messages to agents and their tool sets. This issue has been patched in version 4.5.97.
Risk Information
cvss3
Base: 9.1
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N
Description
PraisonAI is a multi-agent teams system. Prior to version 4.5.90, MCPToolIndex.search_tools() compiles a caller-supplied string directly as a Python regular expression with no validation, sanitization, or timeout. A crafted regex causes catastrophic backtracking in the re engine, blocking the Python thread for hundreds of seconds and causing a complete service outage. This issue has been patched in version 4.5.90.
Risk Information
cvss3
Base: 6.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H
Access Data Using Our API
Get company history
curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?linkedin_id=novo-nordisk' -H 'apikey: YOUR_API_KEY_HERE'
RapidWhat Do We Measure ?
Incident
Finding
Grade
Digital Assets
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
These are some of the factors we use to calculate the overall score:
Network Security
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
SBOM (Software Bill of Materials)
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
CMDB (Configuration Management Database)
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Threat Intelligence
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.
